[contact-form-7 id="15592" title="Tell me more"]

Contact Next Edge Capital

1 Toronto Street, Suite 200
Toronto, ON M5C 2V6

Telephone: 416.775.3600
Toll-free: 1.877.860.1080
Fax: 416.775.3601
Email: info@nextedgecapital.com

How to reduce risk when investing in biotech stocks

Eden Rahim, the portfolio manager and options strategist at Next Edge Capital, joins BNN Bloomberg and discusses the steep decline in biotech stocks, how to reduce the risk when investing in the sector, and several Canadian names that are attractive opportunities....

Read More
U.S. Midterm & Health-care and Biotech

Eden Rahim, portfolio manager and options strategist at Next Edge Capital, joins BNN Bloomberg to provide insight on what the U.S. midterm elections could mean for the health-care and biotech sectors....

Read More
Next Edge Bio-Tech Barometer Chartbook

With the recent sharp decline in global equity markets and Biotech companies, resulting in a – 11% decline for the NBI and a stunning –17% for the XBI, many of the sector’s breadth and sentiment indicators have approached the oversold readings achieved in February. ...

Read More
Up by the escalator, Down by the elevator

Post-2008 Crisis market corrections seem to play out differently to Corrections prior to the crisis. In particular, prior to the crisis, corrections were typically a grind-it-out affair oscillating down for 3-9 months, wearing down investor expectations. ...

Read More
A Blowout Performance Without A FAANG In Sight

The second-best performing mutual fund in the country over the past 12 months does not contain a single share from the high-flying FAANG stocks. Eden Rahim of Next Edge Capital explains how his Next Edge Bi0TEch Plus A fund shot up 47 per cent over...

Read More